PIQUR Therapeutics Overview

  • Founded
  • 2011
Founded
  • Status
  • Private
  • Employees
  • 9
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $6.01M
Latest Deal Amount
  • Investors
  • 3

PIQUR Therapeutics General Information

Description

Developer of targeted oncology and dermatology medicines intended for the treatment of cancer and genetic diseases. The company's drugs are aimed at extending and improving the lives of cancer patients, enabling cancer patients to recover and have a healthy life.

Contact Information

Website
www.piqur.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • Arnold Böcklin-Strasse 25
  • 4051 Basel
  • Switzerland
+41 061 000 00 00

PIQUR Therapeutics Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

PIQUR Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC 15-Apr-2019 $6.01M 000.00 00000 Completed Generating Revenue
8. Later Stage VC (Series B) 15-Nov-2017 Cancelled Generating Revenue
7. Later Stage VC (Series A3) 01-Sep-2017 000.00 000.00 00000 Completed Generating Revenue
6. Early Stage VC (Series A2) 16-Jul-2015 000.00 000.00 00000 Completed Generating Revenue
5. Early Stage VC (Series A) 08-Apr-2014 000.00 000.00 000.00 Completed Generating Revenue
4. Seed Round 05-Sep-2013 00.000 00.000 000.00 Completed Generating Revenue
3. Grant 00.00 Completed Generating Revenue
2. Seed Round 01-Oct-2012 $3.1M $3.1M 00.00 Completed Generating Revenue
1. Seed Round Completed Generating Revenue
To view PIQUR Therapeutics’s complete valuation and funding history, request access »

PIQUR Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary shares 000,000 00.000000 000.00 000.00 00 000.00 0.000
Series A3 0,000,000 00.000000 000.00 000.00 00 000.00 00.000
Series A2 000,000 00.000000 000.00 000.00 00 000.00 00.000
Series A 0,000,000 00.000000 000.00 000.00 00 000.00 00.000
Ordinary shares 000,000 00.000000 000.00 000.00 00 000.00 0.000
Ordinary shares 000,000 00.000000 00.00 00.00 00 00.00 0.000
Ordinary shares 000,000 00.000000 00.00 00.00 00 00.00 0.000
Ordinary shares 43,308 $0.100210 $1.54 $1.54 1x $1.54 0.74%
Ordinary shares 50,000 $0.100210 $0.2 $0.2 1x $0.2 0.85%
To view PIQUR Therapeutics’s complete cap table history, request access »

PIQUR Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of targeted oncology and dermatology medicines intended for the treatment of cancer and genetic diseases. The
Drug Discovery
Basel, Switzerland
9 As of 2021
000.00
0000 0000-00-00
0000000000 0 000.00

000000 0

in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occa
0000 000000000
New York, NY
0 As of 0000
0000
000000&0 0000

0000000

m dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore
0000000000000
Oss, Netherlands
0 As of 0000
000.00
0000 0000-00-00
000000&0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

PIQUR Therapeutics Competitors (42)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Gotham Therapeutics Formerly VC-backed New York, NY 0 0000 000000&0 0000
0000000 0000000000 Formerly VC-backed Oss, Netherlands 0 000.00 000000&0 000.00
000000000 00000000 Formerly VC-backed San Francisco, CA 000 00000 000000&0 00000
000000000 Formerly VC-backed Exton, PA 000 0000 000000&0 0000
000000 00000000 Formerly VC-backed Foster City, CA 00000 00.000 000000&0
You’re viewing 5 of 42 competitors. Get the full list »

PIQUR Therapeutics Executive Team (23)

Name Title Board Seat Contact Info
Peter Oprandi Chief Financial Officer, Head of Business Development & Board Member
Doriano Fabbro Chief Scientific Officer
Bernd Giese Co-Founder
Matthias Wymann Ph.D Co-Founder
Walter Dieterle Head, DMPK
You’re viewing 5 of 23 executive team members. Get the full list »

PIQUR Therapeutics Board Members (12)

Name Representing Role Since
Christian Salz PIQUR Therapeutics Vice Chairman 000 0000
Gianni Gromo Ph.D Versant Ventures Board Member 000 0000
Guido Magni MD Versant Ventures Board Member 000 0000
Peter Oprandi PIQUR Therapeutics Chief Financial Officer, Head of Business Development & Board Member 000 0000
Philippe Andres PIQUR Therapeutics Board Member 000 0000
You’re viewing 5 of 12 board members. Get the full list »

PIQUR Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PIQUR Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Versant Ventures Venture Capital Minority 000 0000 000000 0
Venture Kick Accelerator/Incubator Minority 000 0000 000000 0
Commission for Technology and Innovation Government Minority 000 0000 000000 0
To view PIQUR Therapeutics’s complete investors history, request access »